The invention discloses novel Chinese patent medicine capable of improving cardiac function, which comprises the following raw materials in parts by weight: 12-18 parts of kelp, 5-9 parts of rhizoma anemarrhenae, 8-12 parts of vervain, 15-22 parts of folium artemisiae argyi, 8-17 parts of polygonum cuspidatum, 5-10 parts of crinis ustus, 8-17 parts of teasel root and 5-12 parts of euphorbia kansui. Compared with the existing heart medicine, the novel Chinese patent medicine, disclosed by the invention, can treat rheumatic heart disease, improve the blood-pumping function of the heart, restrain bicuspid valve lesion, reduce the occurrence rate of palpitation and the possibility of rheumatic lesion of the heart, is higher in cure rate of myocardial ischemia and has other advantages, can relieve symptom of a disease within short time and is effective in treatment.